...
首页> 外文期刊>EBioMedicine >Hand foot and mouth disease: Enteroviral load and disease severity
【24h】

Hand foot and mouth disease: Enteroviral load and disease severity

机译:手脚和口腔疾病:肠道病变和疾病严重程度

获取原文
           

摘要

In this article of EBioMedicine, Chunlan Song and colleagues studied 1109 children with hand, foot and mouth disease (HFMD) [1]. They demonstrated that the ones having throat swabs testing positive for a specific enterovirus serotype via RT-PCR had higher viral genomic loads, which correlated with four markers of clinical severity, namely admission to the ICU, CNS complications, LOS over five days and need for IVIG or steroids. This association was significant for patients infected with EV-A71 and less consistent for higher viral genomic loads of CV-A6. The authors observed a decline in viral load over time after illness onset of all HFMD associated enteroviruses. The association was statistically significant for CV-A6, CV-A10 and CV-A4, but not significant for CV-A2, CV-A16, or EV-A71. In the sensitivity analysis, however, the patients whose throat swabs tested negative for enteroviruses but whose stools tested positive for EV-A71 or CV-A16 were included, which allowed detection of a statistically significant difference, which is consistent with the results of previous studies [2]. This is one of the few and the largest investigations to study the association of enterovirus genomic loads among HFMD patients and their clinical severities. It is notable that less than 5% of the children in this study had an underlying medical condition, and none of the patients were immunocompromised.
机译:在本文的eBiomedicine,春兰歌曲和同事研究了1109名儿童手,脚和口腔疾病(HFMD)[1]。他们证明,通过RT-PCR具有喉拭子的喉拭子的乳蛋白酶具有更高的病毒基因组载荷,其与临床严重程度的四个标记相关,即入院对ICU,CNS并发症,洛杉矶超过五天,需要Ivig或类固醇。对于感染EV-A71的患者而言,这种关联对于CV-A6的更高病毒基因组载荷较少的患者非常重要。作者观察到所有HFMD相关肠病病毒的疾病发病后的病毒载量下降。该关联对于CV-A6,CV-A10和CV-A4具有统计学意义,但对于CV-A2,CV-A16或EV-A71不显着。然而,在敏感性分析中,喉部拭子测试为肠道病毒的阴性,但其粪便用于EV-A71或CV-A16阳性,这允许检测统计学上显着差异,这与先前研究的结果一致[2]。这是研究HFMD患者和临床剧性肠道病毒基因组载体协会的少数和最大的研究之一。值得注意的是,这项研究中不到5%的儿童具有潜在的医疗状况,并且没有任何患者免疫普及。

著录项

  • 来源
    《EBioMedicine》 |2020年第5期|共2页
  • 作者

    Stephen K Tyring;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号